PRMA Consulting Associate Director Anja Pownell discusses how the PRMA Tracker® helps assess the HTA and pricing and reimbursement decision landscape in the latest tHEORetically Speaking blog post.
The discussion between Pownell and HealthEconomics.Com CEO Patti Peeples is the third installment of a five-part series on digital transformation in market access.
“Manufacturers often need support when they are moving into a new therapy area or when the treatment paradigm is completely changed by products with a novel mechanism of action, such as CAR-T treatments,” Pownell said.
To read the full tHEORetically Speaking blog post, click here.
